Guggenheim Maintains Buy on CryoPort, Raises Price Target to $19

Benzinga Newsdesk www.benzinga.com Positive 81.1%

Neg 0% Neu 0% Pos 81.1%

Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $16 to $19.

Comments

No comments yet. Be the first!